Veracyte, Rosetta Genomics, NanoString Lead Decliners as Life Science Tools/Omics Stocks Decline in April | GenomeWeb

NEW YORK (GenomeWeb) – Veracyte, Rosetta Genomics, and NanoString Technologies led a lineup of firms in the GenomeWeb Daily News Index that saw their share prices retreat in April, as the Index took a 5 percent hit during the month.

Overall, stocks for 22 of the 29 companies in the Index dropped in April with Veracyte (-25 percent), Rosetta Genomics (-24 percent), and NanoString (-21 percent) pacing the decliners. The gainers were led by Myriad Genetics (+23 percent) and Sequenom (+11 percent) as the only two firms with double-digit percentage increases in April.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.